← Back to headlines
Gilead's Experimental HIV Treatment Shows Low Discontinuation Rates
Gilead Sciences' experimental HIV treatment has demonstrated low discontinuation rates in recent studies, indicating potential for improved patient adherence.
25 Feb, 19:27 — 25 Feb, 19:27
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Australian PM Condemns Alleged Terror Plot Targeting Mosques and Parliament
just now
With HPV vaccine rollout, AIIMS oncologist says it’s the beginning of the end for cervical cancer in India
39m ago
Goodbye giant burger hoardings: Abu Dhabi bans junk food advertising, billboards to go sugar-free amid new public health policy targeting obesity
1h ago
Ghana’s health system must break silos in NTD care and mental health
1h ago